S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
S&P 500   3,636.76 (+1.65%)
DOW   30,057.35 (+1.58%)
QQQ   294.39 (+1.38%)
AAPL   115.33 (+1.30%)
MSFT   212.85 (+1.30%)
FB   276.28 (+2.92%)
GOOGL   1,759.75 (+1.86%)
AMZN   3,119.21 (+0.67%)
TSLA   558.56 (+7.03%)
NVDA   520.10 (-1.05%)
BABA   278.46 (+3.09%)
CGC   26.83 (+8.54%)
GE   10.42 (+3.48%)
MU   63.47 (-1.11%)
AMD   85.21 (-0.12%)
T   29.22 (+2.10%)
NIO   53.93 (-2.62%)
F   9.41 (+6.21%)
ACB   9.04 (+25.91%)
NFLX   481.93 (+1.11%)
GILD   60.63 (+1.24%)
BA   219.41 (+3.73%)
DIS   151.15 (+3.54%)
Log in
OTCMKTS:SIML

Simlatus Stock Forecast, Price & News

$0.0002
0.00 (0.00 %)
(As of 11/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00▼
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00▼
$0.50
Volume7.98 million shs
Average Volume45.21 million shs
Market Capitalization$599,198.00
P/E RatioN/A
Dividend YieldN/A
Beta2.37
Simlatus Corporation develops, manufactures, markets, and owns broadcast equipment and software for broadcast studios worldwide. The company also provides DirecTV services to high-rise apartments, condominiums, and large commercial office buildings in the San Francisco metropolitan area, as well as Internet services. In addition, it manufactures and sells cold-water/alcohol CBD extraction systems for medical grade CBD utilization, as well as climate controlled grow containers for government food-safety programs, and commercial and medical grade CBD. Simlatus Corporation is based in Grass Valley, California.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.52 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Radio & t.v. communications equipment
Sub-IndustryN/A
SectorConsumer Discretionary
Current SymbolOTCMKTS:SIML
Previous Symbol
CUSIPN/A
CIK1399306
Websimlatus.com
Phone530-205-3437
Employees9

Debt

Debt-to-Equity RatioN/A
Current Ratio0.02
Quick Ratio0.02

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$120,000.00
Price / Sales4.99
Cash FlowN/A
Price / Cash FlowN/A
Book Value($15.34) per share
Price / Book0.00

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-52,410,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-74,389.66%

Miscellaneous

Outstanding Shares2,995,990,000
Market Cap$599,198.00
Next Earnings Date11/27/2020 (Estimated)
OptionableNot Optionable
$0.0002
0.00 (0.00 %)
(As of 11/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SIML News and Ratings via Email

Sign-up to receive the latest news and ratings for SIML and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Simlatus (OTCMKTS:SIML) Frequently Asked Questions

How has Simlatus' stock been impacted by Coronavirus?

Simlatus' stock was trading at $0.0001 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, SIML shares have increased by 100.0% and is now trading at $0.0002.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Simlatus?

Wall Street analysts have given Simlatus a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Simlatus wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Simlatus' next earnings date?

Simlatus is scheduled to release its next quarterly earnings announcement on Friday, November 27th 2020.
View our earnings forecast for Simlatus.

Are investors shorting Simlatus?

Simlatus saw a drop in short interest in the month of October. As of October 30th, there was short interest totaling 300 shares, a drop of 99.9% from the October 15th total of 320,000 shares. Based on an average trading volume of 31,478,300 shares, the short-interest ratio is currently 0.0 days.
View Simlatus' Short Interest.

Who are some of Simlatus' key competitors?

Some companies that are related to Simlatus include Andrea Electronics (ANDR), AfterMaster (AFTM), GTX (GTXO), Northstar Electronics (NEIK), COMARCO (CMRO), Proxim Wireless (PRXM), Wegener (WGNR) and ZST Digital Networks (ZSTN).
View all competitors.

What other stocks do shareholders of Simlatus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Simlatus investors own include Co-Diagnostics (CODX), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Actinium Pharmaceuticals (ATNM), BioRestorative Therapies (BRTX) and FuelCell Energy (FCEL).

Who are Simlatus' key executives?

Simlatus' management team includes the following people:
  • Mr. Richard N. Hylen, CEO, Chairman, Pres, Sec. & Treasurer (Age 74, Pay $120k)

What is Simlatus' stock symbol?

Simlatus trades on the OTCMKTS under the ticker symbol "SIML."

How do I buy shares of Simlatus?

Shares of SIML can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Simlatus' stock price today?

One share of SIML stock can currently be purchased for approximately $0.00.

How big of a company is Simlatus?

Simlatus has a market capitalization of $599,198.00 and generates $120,000.00 in revenue each year. Simlatus employs 9 workers across the globe.

What is Simlatus' official website?

The official website for Simlatus is simlatus.com.

How can I contact Simlatus?

Simlatus' mailing address is 175 JOERSCHKE DR. SUITE A, GRASS VALLEY CA, 95945. The company can be reached via phone at 530-205-3437 or via email at [email protected]

This page was last updated on 11/24/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.